Fallon Lin, a highly accomplished scientist, has an impressive career trajectory in the field of biomedical research. She graduated with a Bachelor of Science in Biology from the prestigious Massachusetts Institute of Technology (MIT) and went on to work for Novartis Institutes for BioMedical Research (NIBR), where she held various roles, including Principal Scientist I, Scientist II (Oncology), and Oncology Project Coordinator. Her extensive experience in small molecule drug discovery and oncology research makes her a valuable asset in the pharmaceutical industry.

During her time at NIBR, Fallon excelled in her work, consistently demonstrating a keen analytical mind and an ability to solve complex scientific problems. Her determination to succeed and passion for advancing medical research has led her to advance within the industry quickly. She began her career at NIBR as an Intern in their Summer Program before being hired full-time as a Scientific Associate I. Since then, Fallon has held various roles of increasing responsibility, including Scientific Associate II and Scientist I, before being appointed as Scientist II and Oncology Project Coordinator.

Fallon's work at NIBR focused on oncology research, where she was responsible for the discovery and development of new small molecule drugs. Her work has contributed significantly to the field of oncology, leading to the discovery of several molecular compounds that are currently undergoing clinical trials for the treatment of various cancers.

Overall, Fallon's background in biomedical research, oncology, and drug discovery positions her as a highly qualified and experienced scientist who has achieved tremendous success in her field.